Pneumococcal vaccination may induce anti-oxidized low-density lipoprotein antibodies that have potentially protective effects against cardiovascular disease

Vaccine

Volumn 30, Issue 27, 2012, Pages 3983-3985

  Suthers, B ^a   Hansbro, P ^b   Thambar, S ^a   McEvoy, M ^b   Peel, R ^b   Attia, J ^a,b  

^a JOHN HUNTER HOSPITAL   (Australia)

^b HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Anti oxLDL antibodies; Cardiovascular disease; Ox LDL; Pneumococcal vaccine

Indexed keywords

ANTIBODY; AUTOANTIBODY; IMMUNOGLOBULIN G ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; PNEUMOCOCCAL ANTIBODY; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SELF REPORT; VACCINATION;

AGED; ANTIBODIES, BACTERIAL; ATHEROSCLEROSIS; AUTOANTIBODIES; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; IMMUNOGLOBULIN G; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PNEUMOCOCCAL VACCINES; VACCINATION;

EID: 84861479380     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.03.084     Document Type: Article

References (15)

1. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
2. Lusis A.J. Atherosclerosis. Nature 2000, 407:233-241.
3. Caligiuri G., Khallou-Laschet J., Vandaele M., Gaston A.T., Delignat S., Mandet C., et al. Phosphorylcholine-targeting immunization reduces atherosclerosis. Journal of the American College of Cardiology 2007, 50:540-546.
4. Sjoberg B.G., Su J., Dahlbom I. Low levels of IgM antibodies against phosphorylcholine-a potential marker for ischaemic stroke in men. Atherosclerosis 2009, 203:528-532.
5. Karvonen J.P.M., Kesaniemi Ya, Horkko S. Immunoglobulin M type of autoantibodies to oxidised low density lipoprotein has an inverse relation to carotid artery atherosclerosis. Circulation 2003, 108:2107-2112.
6. Soto Y., Conde H., Aroche R., Brito V., Luaces P., Nasiff A., et al. Autoantibodies to oxidized low density lipoprotein in relation with coronary artery disease. Human Antibodies 2009, 18:109-117.
7. Shoenfeld Y., Wu R., Dearing L.D. Are anti-oxidized low-density lipoprotein antibodies pathogenic or protective?. Circulation 2004, 110:2552-2558.
8. Frostegard J. Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease. Clinical Immunology 2010, 134:47-54.
9. Laczik R., Szodoray P., Veres K., Szomjak E., Csipo I., Sipka S., et al. Assessment of IgG antibodies to oxidized LDL in patients with acute coronary syndrome. Lupus 2011, 20:730-735.
10. Binder C.J., Horkko S., Dewan A., Chang M.K., Kieu E.P., Goodyear C.S., et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidised LDL. Nature Medicine 2003, 9(6):736-743.
11. Binder C.J., Hartvigsen K., Witztum J.L. Promise of immune modulation to inhibit atherogenesis. JACC 2007, 50:547-550.
12. Lamontagne F., Garant M.-P., Carvalho J.-C., Lanthier L., Smieja M., Pilon D. CMAJ 2008, 179(8):773-777.
13. Tseng H.F., Slezak J.M., Quinn V.P., Sy L.S., Van den Eeden S.K., Jacobsen S.J. Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men. JAMA 2010, 303(17):1699-1706.
14. McEvoy M., Smith W., D'Este C., Duke J., Peel R., Schofield P., et al. Cohort profile: the Hunter community Study. International Journal of Epidemiology 2010, 39:1452-1463.
15. Cherubini A., Mecocci P., Senin U., Lowenthal D.T., Barnert G., Chionne F. Autoantibodies against oxidized low density lipoproteins in older stroke patients. Journal of the American Geriatrics Society 1997, 45:125.